| Astal Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 512600 |
NSE Symbol : - |
P/E(TTM) : 31.81 |
|
ISIN Demat : INE307N01014 |
Div & Yield% : 0.00 |
EPS(TTM) : 2.32 |
|
Book Value(₹) : 76.89 |
Market Cap(₹Cr) : 311.51 |
Face Value(₹) : 10.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 52.24 | 37.52 | 25.33 | 23.47 | 14.46 | 13.16 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 52.24 | 37.52 | 25.33 | 23.47 | 14.46 | 13.16 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.04 | 0.03 | 0.06 | 0.04 | 0.06 | 0.00 |
| Total Income | 52.27 | 37.55 | 25.38 | 23.50 | 14.51 | 13.16 |
| Total Expenditure | 48.68 | 33.65 | 22.17 | 19.28 | 11.13 | 10.27 |
| PBIDT | 3.59 | 3.90 | 3.21 | 4.22 | 3.38 | 2.89 |
| Interest | 0.33 | 0.31 | 0.30 | 0.27 | 0.28 | 0.09 |
| PBDT | 3.26 | 3.59 | 2.91 | 3.95 | 3.10 | 2.80 |
| Depreciation | 0.12 | 0.12 | 0.12 | 0.10 | 0.08 | 0.03 |
| Tax | 0.81 | 0.90 | 0.46 | 1.11 | 0.43 | 0.77 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.04 | -0.02 | 0.25 | -0.01 | 0.10 | 0.00 |
| Reported Profit After Tax | 2.36 | 2.58 | 2.09 | 2.74 | 2.49 | 2.00 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 2.36 | 2.58 | 2.09 | 2.74 | 2.49 | 2.00 |
| EPS (Unit Curr.) | 2.19 | 2.40 | 2.13 | 2.80 | 2.53 | 2.04 |
| EPS (Adj) (Unit Curr.) | 2.19 | 2.40 | 2.13 | 2.80 | 2.53 | 2.04 |
| Calculated EPS (Unit Curr.) | 2.19 | 2.39 | 2.12 | 2.79 | 2.53 | 2.03 |
| Calculated EPS (Adj) (Unit Curr.) | 2.19 | 2.39 | 2.12 | 2.79 | 2.53 | 2.03 |
| Calculated EPS (Ann.) (Unit Curr.) | 8.74 | 9.58 | 8.49 | 11.15 | 10.11 | 8.14 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 8.74 | 9.58 | 8.49 | 11.15 | 10.11 | 8.14 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 10.79 | 10.79 | 9.85 | 9.85 | 9.85 | 9.85 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 6.87 | 10.39 | 12.67 | 17.98 | 23.37 | 21.96 |
| PBDTM(%) | 6.24 | 9.57 | 11.49 | 16.83 | 21.44 | 21.28 |
| PATM(%) | 4.52 | 6.88 | 8.25 | 11.67 | 17.22 | 15.20 |
